Redox status and protein binding of plasma aminothiols during the transient hyperhomocysteinemia that follows homocysteine administration.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Clinical Chemistry

• Publication date

  1993-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/CLINCHEM/39.6.980PMID 8504567
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma.

  1992cited by this paper
• Dynamic relation between reduced, oxidized, and protein-bound homocysteine and other thiol components in plasma during methionine loading in healthy men.

  1992influential reference
• Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.

  1992cited by this paper
• Methionine metabolism in mammals.

  1990cited by this paper
• Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.

  1989cited by this paper
• Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects.

  1989cited by this paper
• Interrelations between plasma free and protein-bound homocysteine and cysteine in homocystinuria.

  1988cited by this paper
• The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells.

  1987cited by this paper
• Oxidation of low-density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor.

  1987cited by this paper
• The use of cyst(e)ine in the removal of protein-bound homocysteine.

  1984cited by this paper
• Homocysteine theory of arteriosclerosis: development and current status

  1983cited by this paper
• Homocysteine thiolactone and experimental homocysteinemia.

  1982cited by this paper
• Accumulation of homocyst(e)ine in vitamin B-6 deficiency: a model for the study of cystathionine beta-synthase deficiency.

  1982cited by this paper
• Involvement of the cystathionine pathway in the biosynthesis of glutathione by isolated rat hepatocytes.

  1980cited by this paper
• The metabolic basis of inherited disease

  1961cited by this paper

• Riboflavin and friends: Remarkably versatile vitamins

  2021cites this paper
• Implications of plasma thiol redox in disease.

  2018cites this paper
• Kidney donors and kidney transplants have abnormal aminothiol redox status, and are at increased risk of oxidative stress and reduced redox buffer capacity.

  2014cites this paper
• Impact of calcium binding and thionylation of S100A1 protein on its NMR derived structure and backbone dynamics

  2013cites this paper
• Impact of calcium binding and thionylation of S100A1 protein on its nuclear magnetic resonance-derived structure and backbone dynamics.

  2013cites this paper
• The thiol pool in human plasma: the central contribution of albumin to redox processes.

  2013cites this paper
• Comparative studies on homocysteine and its metabolite–homocysteine thiolactone action in blood platelets in vitro

  2008cites this paper
• Genetic variation in the folate receptor-alpha and methylenetetrahydrofolate reductase genes as determinants of plasma homocysteine concentrations

  2008cites this paper
• Genetic Variation in the Folate Receptor-α and Methylenetetrahydrofolate Reductase Genes as Determinants of Plasma Homocysteine Concentrations

  2008cites this paper
• zur Veränderung des Methylierungspotenzials durch einmalige orale Homocysteinzufuhr bei gesunden Freiwilligen

  2007cites this paper
• Adenosine in health and disease. A human in vivo study on genetic, metabolic, and pharmacological determinants of the cardiovascular effects of adenosine.

  2007cites this paper
• Plasma cysteine and glutathione are independent markers of postmethionine load endothelial dysfunction.

  2007cites this paper
• SUPLEMENTAÇÃO DE CREATINA, HOMOCISTEÍNA E ESTRESSE OXIDATIVO

  2007cites this paper
• SUPLEMENTA˙ˆO DE CREATINA, HOMOCISTE˝NA

  2007cites this paper
• Vascular Oxidant Stress and Inflammation in Hyperhomocysteinemia

  2007cites this paper
• Progressive glycosylation of albumin and its effect on the binding of homocysteine may be a key step in the pathogenesis of vascular damage in diabetes mellitus.

  2007influential citation
• Homocysteine and Glutathione Peroxidase-1

  2007cites this paper
• Plasma levels of the atherogenic amino acid homocysteine in postmenopausal women with breast cancer treated with tamoxifen

  2006cites this paper
• Homocysteinstoffwechsel und Atherosklerose. Methionin-Belastungstests und langfristige Methionin- Applikation im Kaninchenmodell

  2006cites this paper
• Methionine challenge paradoxically induces a greater activation of the antioxidant defence in subjects with hyper- vs. normohomocysteinemia

  2006cites this paper
• Influence of homocysteine on the interaction between circulating monocytes and endothelial cells

  2005cites this paper
• INFLUENCE OF HOMOCYSTEINE ON THE INTERACTION BETWEEN CIRCULATING MONOCYTES AND ENDOTHELIAL CELLS

  2005cites this paper
• Downstream effects on human low density lipoprotein of homocysteine exported from endothelial cells in an in vitro system Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400339-JLR200

  2005cites this paper
• Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.

  2005cites this paper
• Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation.

  2004cites this paper
• A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B(12) and folate deficiency: results from an in vitro experience.

  2004cites this paper
• Enhanced Cellular Adenosine Uptake Limits Adenosine Receptor Stimulation in Patients With Hyperhomocysteinemia

  2004cites this paper
• Oxidative stress and detoxification in reproduction with emphasis on glutathione and preeclampsia

  2003cites this paper
• Influence of Hyperhomocysteinemia on the Cellular Redox State – Impact on Homocysteine-Induced Endothelial Dysfunction

  2003cites this paper
• Homocysteine and oxidative stress

  2003cites this paper
• Potential role for adenosine in the pathogenesis of the vascular complications of hyperhomocysteinemia.

  2003cites this paper
• Plasma aminothiol oxidation in chronic hemodialysis patients.

  2002cites this paper
• Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia

  2002cites this paper
• Vitamin Supplementation Normalizes Total Plasma Homocysteine Concentration but Not Plasma Homocysteine Redox Status in Patients with Acute Coronary Syndromes and Hyperhomocysteinemia

  2002cites this paper
• Homocysteine, a sulphur-containing aminoacid, is an intermediate formed during the catabolism of the essential dietary amino acid methionin (1,2). The factors known to influence homocysteine metabolism are vitamin B12, vitamin B6, folate and genetic aberration in the methylenetetrahydrofolate reduct

  2002cites this paper
• Serum Total Homocysteine and Premature Coronary Heart Disease: Prospective Study in Middle Aged Patients

  2002cites this paper
• Homocystine solubility and vascular disease

  2002influential citation
• Why are homocysteine levels increased in kidney failure? A metabolic approach.

  2002cites this paper
• Plasma reduced homocysteine concentrations are increased in end-stage renal disease.

  2001cites this paper
• Novel approach for the determination of the redox status of homocysteine and other aminothiols in plasma from healthy subjects and patients with ischemic stroke.

  2001cites this paper
• The effects of oral methionine and homocysteine on endothelial function

  2001cites this paper
• Relationships among plasma homocysteine, cysteine, and albumin concentrations: potential utility of assessing the cysteine/homocysteine ratio.

  2001cites this paper
• Fully automated nucleic acid extraction: MagNA Pure LC.

  2001cites this paper
• Vascular Dysfunction in Hyperhomocyst(e)inemia. Implications for Atherothrombotic Disease

  2001cites this paper
• Albumin Thiolate Anion Is an Intermediate in the Formation of Albumin-S–S-Homocysteine*

  2001cites this paper
• Impaired Homocysteine Metabolism and Atherothrombotic Disease

  2001cites this paper
• The kidney and homocysteine metabolism.

  2001cites this paper
• Animal models of diet-induced atherosclerosis.

  2001cites this paper
• Investigation of Relationship Between Reduced, Oxidized, and Protein-Bound Homocysteine and Vascular Endothelial Function in Healthy Human Subjects

  2001cites this paper
• Plasma Total Cysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project

  2001cites this paper
• Relative Roles of Albumin and Ceruloplasmin in the Formation of Homocystine, Homocysteine-Cysteine-mixed Disulfide, and Cystine in Circulation*

  2001cites this paper
• Consequences of Homocysteine Export and Oxidation in the Vascular System

  2000cites this paper
• Homocysteine and atherothrombosis--mechanisms for injury.

  2000cites this paper
• Biological and Environmental Determinants of Plasma Homocysteine

  2000cites this paper
• Mechanisms for the formation of protein-bound homocysteine in human plasma.

  2000cites this paper
• Plasma Thiol Status in Preeclampsia

  2000cites this paper
• Homocysteine and Cholesterol: Basic and Clinical Interactions

  2000cites this paper
• Biochemistry and Metabolism

  2000cites this paper
• 3. BIOCHEMISTRY AND METABOLISM

  2000cites this paper
• Homocysteine.

  1999cites this paper
• Homocysteine: cholesterol of the 90s?

  1999cites this paper
• Lifestyle and cardiovascular disease risk factors as determinants of total cysteine in plasma: the Hordaland Homocysteine Study.

  1999cites this paper
• Protein binding of homocysteine and other thiols in HeLa cell cultures after addition of homocysteine and copper ions.

  1998cites this paper
• Clinical chemistry and molecular biology of homocysteine metabolism: an update.

  1997cites this paper
• Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project.

  1997cites this paper
• Homocysteine Metabolism: From Basic Science to Clinical Medicine

  1997cites this paper
• Assessment of homocysteine status

  1997cites this paper
• Homocysteine and Drug Therapy

  1997cites this paper
• Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice.

  1997cites this paper
• Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection.

  1996cites this paper
• Homocysteine species as components of plasma redox thiol status.

  1995cites this paper
• Lipid peroxidation and susceptibility of low‐density lipoprotein to in vitro oxidation in hyperhomocysteinaemia

  1995cites this paper
• Determination of total plasma homocysteine and related aminothiols by gas chromatography with flame photometric detection.

  1995cites this paper
• Determination of total serum sulfite by HPLC with fluorescence detection.

  1995cites this paper
• Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease.

  1995cites this paper
• Effect of thiol oxidation and thiol export from erythrocytes on determination of redox status of homocysteine and other thiols in plasma from healthy subjects and patients with cerebral infarction.

  1995cites this paper
• Pathobiochemical implications of hyperhomocysteinemia

  1994cites this paper
• Redox status and protein binding of plasma homocysteine and other aminothiols in patients with hyperhomocysteinemia due to cobalamin deficiency.

  1994cites this paper
• Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects.

  1994cites this paper
• Plasma homocysteine and thiol compound fractions after oral administration of N-acetylcysteine.

  1994cites this paper
• Total Homocysteine in Plasmaor Serum:Methodsand ClinicalApplications

  1993cites this paper
• Total homocysteine in plasma or serum: methods and clinical applications.

  1993cites this paper
• Redox status and protein binding of plasma homocysteine and other aminothiols in patients with homocystinuria.

  1993cites this paper
• Table 1. Ratios of abundance of various FAEEs relative to the serum/acetone volumes used. FAEE Ratio 1

  year unknowncites this paper